Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Collaboration established for research into beta-cell regeneration in diabetes

March 14, 2011

FDA removes clinical hold on AT-2220 for Pompe's disease

March 10, 2011

FDA accepts for review dapagliflozin NDA for type 2 diabetes

March 9, 2011

Endo Pharma launches Fortesta testosterone gel in U.S.

March 8, 2011

DURATION-6 trial of diabetes therapy Bydureon misses primary endpoint

March 4, 2011

Enrollment complete in pivotal Breeze 3 trial of Serada for menopausal hot flashes

March 3, 2011

New inverse agonist of glycoprotein hormone TSH receptor with potential to treat Graves' disease

March 3, 2011

Novel inhibitors of 11-beta-HSD1 presented

March 2, 2011

NPS Pharma advances pivotal REPLACE trial of NPSP-558 in hypoparathyroidism

March 2, 2011

Regeneron reports new phase III data on Arcalyst for prevention of gout flares

March 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.